Novartis Sheds Nicotine Patches To Clear Way For Glaxo Deal
Novartis AG will divest its Habitrol line of nicotine patches in exchange for Federal Trade Commission approval of a joint venture with GlaxoSmithKline PLC, the FTC said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article